March 06, 2014
Article
Reader essay
FDA Approves Biosimilars for Cancer-Related Skeletal Events
Imfinzi Plus Chemo May Improve Event-Free Survival in Gastric, GEJ Cancers
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset
The Dawn of a New Era in Cancer Treatment